These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17681004)

  • 101. Sucralfate versus alginate/antacid in the treatment of peptic esophagitis.
    Evreux M
    Am J Med; 1987 Sep; 83(3B):48-50. PubMed ID: 2821808
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Diagnostic value of alginate test in gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Droxzdov VN; Firsova LD; Kozhurina TS
    Eksp Klin Gastroenterol; 2010; (12):102-7. PubMed ID: 21560632
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Treatment of moderate to severe gastro-oesophageal reflux with an alginate/antacid combination.
    Hasan SS
    Curr Med Res Opin; 1980; 6(10):645-8. PubMed ID: 7428400
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [pH gradient support and antacid action of gastroesophageal coating agents. In vitro pharmacologic study using a model of "the artificial stomach"].
    Vatier J; Vitre MT; Vallot T; Mignon M
    Gastroenterol Clin Biol; 1990; 14(5):414-22. PubMed ID: 2163935
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [Failure of amiodarone in supraventricular tachycardia in an infant: drug interaction with Gaviscon(®)?].
    Chantepie A; Lefort B; Méot M; Jandali JC; Soulé N; Chantreuil J; Vaillant MC; Tisseron B
    Arch Pediatr; 2014 Jun; 21(6):663-4. PubMed ID: 24768351
    [No Abstract]   [Full Text] [Related]  

  • 106. A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms.
    Giannini EG; Zentilin P; Dulbecco P; Iiritano E; Bilardi C; Savarino E; Mansi C; Savarino V
    Dig Dis Sci; 2006 Nov; 51(11):1904-9. PubMed ID: 16977507
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The effect of omeprazole pre-treatment on rafts formed by reflux suppressant tablets containing alginate.
    Dettmar PW; Little SL; Baxter T
    J Int Med Res; 2005; 33(3):301-8. PubMed ID: 15938591
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Antacids and cimetidine treatment for gastro-oesophageal reflux and peptic oesophagitis.
    Cucchiara S; Staiano A; Romaniello G; Capobianco S; Auricchio S
    Arch Dis Child; 1984 Sep; 59(9):842-7. PubMed ID: 6385868
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Gastro-oesophageal reflux in infants. Evaluation of treatment by pH monitoring.
    Vandenplas Y; Sacré-Smits L
    Eur J Pediatr; 1987 Sep; 146(5):504-7. PubMed ID: 3678277
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The alginate raft: a scintigraphic evaluation.
    McKay AP; Wraight EP; Hunter JO
    Br J Clin Pract Suppl; 1989 Feb; 66():20-4; discussion 35-6. PubMed ID: 2511919
    [No Abstract]   [Full Text] [Related]  

  • 111. Trial of gaviscon in the treatment of gastro-oesophageal reflux of infancy.
    Weldon AP; Robinson MJ
    Aust Paediatr J; 1972 Oct; 8(5):279-81. PubMed ID: 4349107
    [No Abstract]   [Full Text] [Related]  

  • 112. Comparative intragastric pH profile of Algicon versus Gaviscon.
    Stoddard CJ; Morgan GE
    Br J Clin Pract Suppl; 1989 Feb; 66():29-34; discussion 35-6. PubMed ID: 2556174
    [No Abstract]   [Full Text] [Related]  

  • 113. Alginate controls heartburn in patients with erosive and nonerosive reflux disease.
    Savarino E; de Bortoli N; Zentilin P; Martinucci I; Bruzzone L; Furnari M; Marchi S; Savarino V
    World J Gastroenterol; 2012 Aug; 18(32):4371-8. PubMed ID: 22969201
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Editorial: simultaneous prolonged monitoring of the acid pocket and oesophageal reflux.
    Katz PO; Castell DO
    Aliment Pharmacol Ther; 2020 Jul; 52(2):397-398. PubMed ID: 32592251
    [No Abstract]   [Full Text] [Related]  

  • 115. Severe hypokalaemic metabolic alkalosis following ingestion of gaviscon.
    Gawarammana IB; Coburn J; Greene S; Dargan PI; Jones AL
    Clin Toxicol (Phila); 2007; 45(2):176-8. PubMed ID: 17364637
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Editorial: simultaneous, prolonged monitoring of the acid pocket and oesophageal reflux. Authors' reply.
    Ma ZF; Deraman MA; Coyle C; Lee YY
    Aliment Pharmacol Ther; 2020 Jul; 52(2):398-399. PubMed ID: 32592257
    [No Abstract]   [Full Text] [Related]  

  • 117. Rheological investigation of the shear strength, durability, and recovery of alginate rafts formed by antacid medication in varying pH environments.
    Elliott BM; Steckbeck KE; Murray LR; Erk KA
    Int J Pharm; 2013 Nov; 457(1):118-23. PubMed ID: 24095816
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Echo-planar magnetic resonance imaging of Gaviscon alginate rafts in-vivo.
    Marciani L; Little SL; Snee J; Coleman NS; Tyler DJ; Sykes J; Jolliffe IG; Dettmar PW; Spiller RC; Gowland PA
    J Pharm Pharmacol; 2002 Oct; 54(10):1351-6. PubMed ID: 12396296
    [TBL] [Abstract][Full Text] [Related]  

  • 119. [Alginate improves symptom control].
    Siegmund-Schultze N
    MMW Fortschr Med; 2016 Jun; 158(11):76. PubMed ID: 27271425
    [No Abstract]   [Full Text] [Related]  

  • 120. Alginate-antacid in the reduction of gastro-oesophageal reflux.
    Stanciu C; Bennett JR
    Lancet; 1974 Jan; 1(7848):109-11. PubMed ID: 4130309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.